Vaginal Inserted Estradiol Pharmaceutical Compositions And Methods

Abstract

In one aspect, compositions and methods for the treatment of vulvovaginal atrophy (VVA) are provided. In one embodiment, the method comprises administering an estrogen to a subject having VVA by inserting a dosage form comprising a liquid pharmaceutical composition.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 16, 2019
  • Application: Feb 9, 2018
    US US 201815893546 A
  • Priority: Feb 9, 2018
    US US 201815893546 A
  • Priority: Dec 7, 2016
    US US 201615372385 A
  • Priority: Jun 10, 2016
    US US 201662348820 P
  • Priority: Apr 29, 2016
    US US 201662329940 P
  • Priority: Apr 19, 2016
    US US 201662324838 P
  • Priority: Feb 17, 2016
    US US 201662296552 P
  • Priority: Dec 7, 2015
    US US 201562264309 P
  • Priority: Oct 22, 2014
    US US 201414521230 A

Download Citation


Sign in to the Lens

Feedback